Pmh77 - Assessment of Health-Related Quality of Life by the Sf36v2 in a Phase 2, Randomized, Placebo-Controlled Trial of the Gabaa Receptor Positive Allosteric Modulator Sage-217 in Major Depressive Disorder

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2888
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pmh76 - Patient Reported Measures of Depressive Symptoms and Fatigue in a Phase 2, Randomized, Placebo-Controlled Trial of the Gabaa Receptor Positive Allosteric Modulator Sage-217 in Major Depressive Disorder

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Trial of SAGE-217 in Patients With Major Depressive Disorder

New England Journal of Medicine
Medicine
2019English

A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder

Biological Psychiatry
Biological Psychiatry
2014English

A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2009English

Long-Term Follow-Up on Health-Related Quality of Life in Major Depressive Disorder: A 2-Year European Cohort Study

Neuropsychiatric Disease and Treatment
2018English

The Anti-Convulsant Stiripentol Acts Directly on the GABAA Receptor as a Positive Allosteric Modulator

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2009English

A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2012English

Efficacy of Eye Movement Desensitization and Reprocessing on the Quality of Life in Patients With Major Depressive Disorder: A Randomized Clinical Trial

Psychology Research and Behavior Management
PsychiatryMental HealthPsychology
2020English

Impact of Aerobic Exercise on Muscle Mass in Patients With Major Depressive Disorder: A Randomized Controlled Trial

Neuropsychiatric Disease and Treatment
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy